LARIMAR THERAPEUTICS

Larimar Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company’s lead compound, CTI-1601, is currently being evaluated in a Phase 1 clinical program as a potential treatment for Friedreich’s ataxia, a rare and progressive genetic disease. Larimar also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds.

LARIMAR THERAPEUTICS

Social Links:

Industry:

Biotechnology Medical Therapeutics

Founded:

2005-01-01

Address:

Bala Cynwyd, Pennsylvania, United States

Country:

United States

Website Url:

http://www.larimartx.com

Total Employee:

11+

Status:

Active

Contact:

844-511-9056

Email Addresses:

[email protected]

Total Funding:

250.18 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome Global Site Tag Mobile Non Scaleable Content

Similar Organizations

adagene-logo

Adagene

Adagene is a clinical-stage biotech company that specializes in developing immuno-oncology antibodies.

aerovate-therapeutics-logo

Aerovate Therapeutics

Aerovate Therapeutics is a biotechnology company focused on developing drugs for rare cardiopulmonary disease.

not_available_image

Avistone Pharmaceuticals

Avistone Pharmaceuticals is a clinical-stage biotechnology company focused on precision oncology therapeutics.

cocrystal-pharma-logo

Cocrystal Pharma

Cocrystal Pharma, Inc. is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics.

electra-therapeutics-logo

Electra Therapeutics

Electra Therapeutics is a clinical stage biotechnology company developing therapies for cancer and other immunological diseases.

global-blood-therapeutics-logo

Global Blood Therapeutics

GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.

inhibrx-logo

Inhibrx

Inhibrx is a clinical-stage biotechnology company focused on developing a broad pipeline of novel biologic therapeutic candidates.

juventas-therapeutics-logo

Juventas Therapeutics

Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.

magenta-therapeutics-logo

Magenta Therapeutics

Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology.

ose-immunotherapeutics-logo

OSE Immunotherapeutics

OSE Immunotherapeutics is a clinical-stage biotechnology company focused on developing.

pluristem-therapeutics-logo

Pluristem Therapeutics

Pluristem Therapeutics is a biotherapy company using placental cells and a 3D technology platform to develop cell therapies for diseases.

potenza-therapeutics-logo

Potenza Therapeutics

Potenza Therapeutics is a preclinical-stage biotechnology company focused on building a portfolio of oncology programs.

lenz-therapeutics-logo

LENZ Therapeutics

LENZ Therapeutics is a late-stage clinical company developing innovative ophthalmic pharmaceutical products.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

translate-bio-logo

Translate Bio

Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.

sensei-biotherapeutics-logo

Sensei Biotherapeutics

Sensei Biotherapeutics is a clinical-stage biotechnology company specializing in the field of next-generation cancer immunotherapies.

tango-therapeutics-logo

Tango Therapeutics

Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.

theolytics-logo

Theolytics

Theolytics is a pre-clinical stage biotechnology company developing next-generation oncolytic viral therapies.

viracta-therapeutics-logo

Viracta Therapeutics

Viracta Therapeutics is a precision oncology company focused on new treatment of virus-associated malignancies.

Current Advisors List

bruce-booth_image

Bruce Booth Member of the Board of Directors @ Larimar Therapeutics
Board_member
2006-08-01

kevin-starr_image

Kevin Starr Member of the Board of Directors @ Larimar Therapeutics
Board_member

fran-heller_image

Fran Heller Board of Directors @ Larimar Therapeutics
Board_member
2014-05-01

thomas-e-hughes_image

Thomas E. Hughes Board Member @ Larimar Therapeutics
Board_member

peter-barrett_image

Peter Barrett Member of the Board of Directors @ Larimar Therapeutics
Board_member

avi-goldberg_image

Avi Goldberg Board Director @ Larimar Therapeutics
Board_member

lou-tartaglia_image

Lou Tartaglia Board of Directors @ Larimar Therapeutics
Board_member

robert-perez_image

Robert Perez Board Member @ Larimar Therapeutics
Board_member
2015-09-01

Current Employees Featured

david-bettoun_image

David Bettoun
David Bettoun Vice President of Discovery and non-Clinical R&D @ Larimar Therapeutics
Vice President of Discovery and non-Clinical R&D
2016-01-01

michael-celano_image